- call +1-201-465-4211
- email sales@mrinsights.biz
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures. Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood.
Scope of the Report:
This report studies the Cardiopulmonary Autotransfusion Systems market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cardiopulmonary Autotransfusion Systems market by product type and applications/end industries.
Autotransfusion involves the collection of blood before surgeries and its transfusion during cardiac. The increasing prevalence of cardiac diseases has led to rise in cardiac surgeries which has propelled the cardiopulmonary autotransfusion market globally. According to the American Heart Association, globally over 80 million people suffer from heart health problems. This is occurring due to change in life style of people and consumption of high amount of fats and sugar. The complication in allogenic blood transfusion which results in significant loss of blood during cardiac surgery has led to the rise in demand for cardiopulmonary autotransfusion systems. Beside that innovation in the autotransfusion system due to advancement in technology has also boosted the global market of cardiopulmonary autotransfusion devices. Lack of availability of skilled professional for operating cardiopulmonary autotransfusion devices can restrain the growth of this market.
The Americas will continue to lead the market during the forecast period and is expected to occupy more than 45% of the overall market. Much of the region’s growth can be attributed to the rise in cardiovascular diseases (CVDs) and the subsequent mortality cases. The surge in cardiac surgeries has accelerated the demand for cardiopulmonary autotransfusion systems among medical facilities as this offers safe and efficient blood transfusion. Factors such as increased investments in R&D to develop innovative products that are superior in design and use will positively influence the market growth in this region.
The global Cardiopulmonary Autotransfusion Systems market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cardiopulmonary Autotransfusion Systems.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Advancis Surgical
Fresenius Kabi
Haemonetics
LivaNova
Medtronic
Terumo
Atrium Medical
Global Blood Resources
Redax
Sarstedt
Stryker
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Unwashed ATS
Washed ATS
Market Segment by Applications, can be divided into
Heart Surgery
Great Organ Transplant Surgery
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Cardiopulmonary Autotransfusion Systems Market Overview
1.1 Product Overview and Scope of Cardiopulmonary Autotransfusion Systems
1.2 Classification of Cardiopulmonary Autotransfusion Systems by Types
1.2.1 Global Cardiopulmonary Autotransfusion Systems Revenue Comparison by Types (2017-2023)
1.2.2 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Types in 2017
1.2.3 Unwashed ATS
1.2.4 Washed ATS
1.3 Global Cardiopulmonary Autotransfusion Systems Market by Application
1.3.1 Global Cardiopulmonary Autotransfusion Systems Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Heart Surgery
1.3.3 Great Organ Transplant Surgery
1.3.4 Others
1.4 Global Cardiopulmonary Autotransfusion Systems Market by Regions
1.4.1 Global Cardiopulmonary Autotransfusion Systems Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cardiopulmonary Autotransfusion Systems Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cardiopulmonary Autotransfusion Systems Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cardiopulmonary Autotransfusion Systems Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cardiopulmonary Autotransfusion Systems Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cardiopulmonary Autotransfusion Systems Status and Prospect (2013-2023)
1.5 Global Market Size of Cardiopulmonary Autotransfusion Systems (2013-2023)
2 Manufacturers Profiles
2.1 Advancis Surgical
2.1.1 Business Overview
2.1.2 Cardiopulmonary Autotransfusion Systems Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Advancis Surgical Cardiopulmonary Autotransfusion Systems Revenue, Gross Margin and Market Share (2016-2017)
2.2 Fresenius Kabi
2.2.1 Business Overview
2.2.2 Cardiopulmonary Autotransfusion Systems Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Revenue, Gross Margin and Market Share (2016-2017)
2.3 Haemonetics
2.3.1 Business Overview
2.3.2 Cardiopulmonary Autotransfusion Systems Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Haemonetics Cardiopulmonary Autotransfusion Systems Revenue, Gross Margin and Market Share (2016-2017)
2.4 LivaNova
2.4.1 Business Overview
2.4.2 Cardiopulmonary Autotransfusion Systems Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 LivaNova Cardiopulmonary Autotransfusion Systems Revenue, Gross Margin and Market Share (2016-2017)
2.5 Medtronic
2.5.1 Business Overview
2.5.2 Cardiopulmonary Autotransfusion Systems Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Medtronic Cardiopulmonary Autotransfusion Systems Revenue, Gross Margin and Market Share (2016-2017)
2.6 Terumo
2.6.1 Business Overview
2.6.2 Cardiopulmonary Autotransfusion Systems Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Terumo Cardiopulmonary Autotransfusion Systems Revenue, Gross Margin and Market Share (2016-2017)
2.7 Atrium Medical
2.7.1 Business Overview
2.7.2 Cardiopulmonary Autotransfusion Systems Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Atrium Medical Cardiopulmonary Autotransfusion Systems Revenue, Gross Margin and Market Share (2016-2017)
2.8 Global Blood Resources
2.8.1 Business Overview
2.8.2 Cardiopulmonary Autotransfusion Systems Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Global Blood Resources Cardiopulmonary Autotransfusion Systems Revenue, Gross Margin and Market Share (2016-2017)
2.9 Redax
2.9.1 Business Overview
2.9.2 Cardiopulmonary Autotransfusion Systems Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Redax Cardiopulmonary Autotransfusion Systems Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sarstedt
2.10.1 Business Overview
2.10.2 Cardiopulmonary Autotransfusion Systems Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sarstedt Cardiopulmonary Autotransfusion Systems Revenue, Gross Margin and Market Share (2016-2017)
2.11 Stryker
2.11.1 Business Overview
2.11.2 Cardiopulmonary Autotransfusion Systems Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Stryker Cardiopulmonary Autotransfusion Systems Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cardiopulmonary Autotransfusion Systems Market Competition, by Players
3.1 Global Cardiopulmonary Autotransfusion Systems Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cardiopulmonary Autotransfusion Systems Players Market Share
3.2.2 Top 10 Cardiopulmonary Autotransfusion Systems Players Market Share
3.3 Market Competition Trend
4 Global Cardiopulmonary Autotransfusion Systems Market Size by Regions
4.1 Global Cardiopulmonary Autotransfusion Systems Revenue and Market Share by Regions
4.2 North America Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
4.3 Europe Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
4.5 South America Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
5 North America Cardiopulmonary Autotransfusion Systems Revenue by Countries
5.1 North America Cardiopulmonary Autotransfusion Systems Revenue by Countries (2013-2018)
5.2 USA Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
5.3 Canada Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
5.4 Mexico Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
6 Europe Cardiopulmonary Autotransfusion Systems Revenue by Countries
6.1 Europe Cardiopulmonary Autotransfusion Systems Revenue by Countries (2013-2018)
6.2 Germany Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
6.3 UK Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
6.4 France Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
6.5 Russia Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
6.6 Italy Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Cardiopulmonary Autotransfusion Systems Revenue by Countries
7.1 Asia-Pacific Cardiopulmonary Autotransfusion Systems Revenue by Countries (2013-2018)
7.2 China Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
7.3 Japan Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
7.4 Korea Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
7.5 India Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
8 South America Cardiopulmonary Autotransfusion Systems Revenue by Countries
8.1 South America Cardiopulmonary Autotransfusion Systems Revenue by Countries (2013-2018)
8.2 Brazil Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
8.3 Argentina Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
8.4 Colombia Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Cardiopulmonary Autotransfusion Systems by Countries
9.1 Middle East and Africa Cardiopulmonary Autotransfusion Systems Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
9.3 UAE Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
9.4 Egypt Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
9.6 South Africa Cardiopulmonary Autotransfusion Systems Revenue and Growth Rate (2013-2018)
10 Global Cardiopulmonary Autotransfusion Systems Market Segment by Type
10.1 Global Cardiopulmonary Autotransfusion Systems Revenue and Market Share by Type (2013-2018)
10.2 Global Cardiopulmonary Autotransfusion Systems Market Forecast by Type (2018-2023)
10.3 Unwashed ATS Revenue Growth Rate (2013-2023)
10.4 Washed ATS Revenue Growth Rate (2013-2023)
11 Global Cardiopulmonary Autotransfusion Systems Market Segment by Application
11.1 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Application (2013-2018)
11.2 Cardiopulmonary Autotransfusion Systems Market Forecast by Application (2018-2023)
11.3 Heart Surgery Revenue Growth (2013-2018)
11.4 Great Organ Transplant Surgery Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Cardiopulmonary Autotransfusion Systems Market Size Forecast (2018-2023)
12.1 Global Cardiopulmonary Autotransfusion Systems Market Size Forecast (2018-2023)
12.2 Global Cardiopulmonary Autotransfusion Systems Market Forecast by Regions (2018-2023)
12.3 North America Cardiopulmonary Autotransfusion Systems Revenue Market Forecast (2018-2023)
12.4 Europe Cardiopulmonary Autotransfusion Systems Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cardiopulmonary Autotransfusion Systems Revenue Market Forecast (2018-2023)
12.6 South America Cardiopulmonary Autotransfusion Systems Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cardiopulmonary Autotransfusion Systems Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Cardiopulmonary Autotransfusion Systems Picture
Table Product Specifications of Cardiopulmonary Autotransfusion Systems
Table Global Cardiopulmonary Autotransfusion
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
